Ageing, cognition and dementia

Age and Ageing

Volumn 26, Issue SUPPL. 4, 1997, Pages 20-23

  Huppert, Felicia ^a   Wilcock, Gordon ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; COGNITION; CONFERENCE PAPER; DEMENTIA; PRIORITY JOURNAL;

EID: 0031475117     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/26.suppl_4.20     Document Type: Conference Paper

References (15)

1. Brayne C, Harrington CR, Wischik CM, Huppert FA, Chi LY, Xuereb JH et al. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population. Dementia 1996; 7: 169-74.
2. Huppert FA, Brayne C, Gertz H-J, Chi LY, Wischik C, Paykel ES. 6-Year Clinical and Neuropathological Follow-up of Very Mild Dementia in an Elderly Population Sample [abstract]. Lancet Conference 'Challenge of the Dementias', Edinburgh, 25-6 April 1996.
3. Lindenberger P, Baltes PB. Sensory functioning and intelligence in old age: a strong correlation. Psychol Aging 1994; 9: 339-55.
4. Huppert FA, Brayne C, Gill C, Paykel ES, Beardsall L. CAMCOG - A concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample. Br J Clin Psychol 1995; 34: 529- 41.
5. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State Examination. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
6. Medical Research Council Cognitive Function and Ageing Study. Cognitive function and dementia in six areas of England and Wales: the distribution of MMSE and prevalence of GMS organicity level in the MRC-CFA Study. Psychol Med (in press).
7. Chadwick C. The MRC Multicentre Study of Cognitive Function and Ageing: a EURODEM incidence study in progress. Neuroepidemiology 1992; 11 (suppl 1): 37-43.
8. Roth M, Huppert FA, Tym E, Mountjoy CQ. CAMDEX: The Cambridge Examination for Mental Disorders of the Elderly 1988. Cambridge: Cambridge University Press, 1988.
9. Kennard ML, Feldman H, Yamada T, Jefferies WA. Serum levels of the iron binding p97 protein are elevated in Alzheimer's disease. Nature Med 1996; 2: 1230-5.
10. Amar K, Lewis T, Wilcock G, Scott M, Bucks R. The relationship between white matter low attenuation on brain CT and vascular risk factors: a memory' clinic study. Age Ageing 1995; 24: 411-5.
11. Forstl H, Burns A, Levy R, Cairns N, Luthert P, Lantos P. Neurologic signs in Alzheimer's disease. Results of a prospective clinical and neuropathologic study. Arch Neurol 1992; 49: 1038-42.
12. Lampe I, Bird TH, Nochlin D, Nemens E, Risse SC, Sumi SM et al. Phenotype chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann Neurol 1994; 36: 368-78.
13. Bird TD, Levy-Lahad E, Poorkaj P, Sharma V, Nemens E, Lahad A et al. Wide range in age of onset for chromosome 1-related familial Alzheimer's disease. Ann Neurol 1996; 40: 932-6.
14. Grady I, Haxby JV, Schapiro MB, Gonzalez Aviles A, Kumar A, Ball MJ et al. Subgroups in dementia of the Alzheimer type identified using positron emission tomography. J Neuropsychiatr Clin Neurosci 1990; 2: 373-84.
15. Wilcock GK, Esiri MM, Bowen DM, Hughes AO. The differential involvement of sub-cortical nuclei in senile dementia of Alzheimer's type. J Neurol Neurosurg Psychiatr 1988; 51: 842-9.